Press-release for stocks published on this month for jnj

Prices are updated after-hours

Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

published : This month symbols : Jnj source : Www.prnewswire.com

save search

Prostate Cancer: Advancements in Prevention and Treatment Drive Global Market Growth
Published: 2024-04-17 (Crawled : 09:00) - prnewswire.com
SNYNF | News | $92.7 600K

|

Health Technology

| 0.63% | O: 0.12% H: 0.51% C: 0.51%
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| -0.08% | O: -0.04% H: 0.28% C: -0.16%
SNY | News | $46.135 1.64% 270K

|

Health Technology

| -0.78% | O: 1.05% H: 0.0% C: 0.0%
treatment global growth market

Robbins Geller Rudman & Dowd LLP, Lieff Cabraser Heimann & Bernstein LLP, and Dugan Law Firm, APLC Announce a $78 Million Class Action Settlement for Third Party Payors That Paid or Reimbursed Costs for Prescription Opioids or Treatment Related to Opioid Misuse, Addiction, and/or Overdose
Published: 2024-04-15 (Crawled : 20:00) - prnewswire.com
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| -2.16% | O: -2.09% H: 0.0% C: 0.0%
opioid million treatment for

Gastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLC
Published: 2024-04-15 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $92.7 600K

|

Health Technology

| -0.22% | O: -0.53% H: 0.61% C: 0.61%
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| -2.2% | O: -0.04% H: 0.0% C: 0.0%
ABBV | News | $165.09 0.26% 760K

|

Health Technology

| 0.52% | O: 0.13% H: 0.11% C: -1.73%
SNY | News | $46.135 1.64% 270K

|

Health Technology

| -1.01% | O: 1.95% H: 0.0% C: 0.0%
research global gastrointestinal therapeutics

DIGITAL THERAPEUTICS STARTUP RESPIREE™ ANNOUNCES INCORPORATION IN US WITH RESIDENCY AT JLABS @ SAN FRANCISCO
Published: 2024-04-15 (Crawled : 07:00) - prnewswire.com
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| -2.2% | O: -0.04% H: 0.0% C: 0.0%
therapeutics

Legal-Bay Lawsuit Funding and West Essex Boosters Announce 2024 West Essex Wrestling Lifetime Achievement Scholarship Winners
Published: 2024-04-12 (Crawled : 11:00) - prnewswire.com
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| -3.82% | O: -1.65% H: 0.0% C: 0.0%
west funding

Usher Syndrome Market to Exhibit Growth at a CAGR of 10.55% by 2034 | DelveInsight
Published: 2024-04-11 (Crawled : 22:00) - prnewswire.com
ALPMF | $9.17 16K

|

Health Technology

| -7.3% | O: -100.0% H: NaN% C: Infinity%
ALPMY | $9.47 520K

|

| -9.23% | O: -8.65% H: 3.19% C: 1.6%
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| -3.82% | O: -1.65% H: 0.0% C: 0.0%
LLY | $745.04 -0.12% 410K

|

Health Technology

| -1.16% | O: -0.0% H: 0.52% C: -1.04%
growth market

New Nationwide Study Finds Majority of Hispanic & Latino/a Employees in the U.S. Experience Pressure to Assimilate and Downplay Aspects of their Personality in Order to Succeed at Work
Published: 2024-04-10 (Crawled : 21:00) - prnewswire.com
MS | News | $90.92 0.73% 950K

|

| -1.87% | O: -0.74% H: 0.09% C: -5.32%
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| -4.43% | O: -0.64% H: 0.0% C: 0.0%
work order nationwide study

Consumer Healthcare Market, 33% of Growth to Originate from North America, Technavio
Published: 2024-04-10 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 600K

|

Health Technology

| -1.64% | O: -100.0% H: NaN% C: Infinity%
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| -4.43% | O: -0.64% H: 0.0% C: 0.0%
ABT | News | $107.145 1.78% 1.3M

|

Health Technology

| -4.29% | O: 0.43% H: 0.3% C: -0.18%
SNY | News | $46.135 1.64% 270K

|

Health Technology

| -3.95% | O: 0.05% H: 0.0% C: 0.0%
growth

The Trillion-Dollar Mark: Corporate Misconduct Cases Reach a Dubious Milestone
Published: 2024-04-10 (Crawled : 16:00) - prnewswire.com
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| -4.23% | O: 0.21% H: 0.0% C: 0.0%
reach milestone

INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Shockwave Medical, Inc. - SWAV
Published: 2024-04-10 (Crawled : 00:00) - prnewswire.com
MODN | $29.85 0.27% 100K

|

Technology Services

| -0.08% | O: -0.49% H: 0.2% C: -0.07%
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| -4.23% | O: 0.21% H: 0.0% C: 0.0%
SWAV | $327.81 0.09% 270K

|

Health Technology

| 0.05% | O: -0.32% H: 1.09% C: 1.02%

enGene Announces Hiring of Dr. Raj Pruthi as Senior Vice President, Urologic Oncology and Clinical Development
Published: 2024-04-09 (Crawled : 12:30) - prnewswire.com
ENGN | $14.58 2.89% 4.4K

|

| -5.45% | O: -4.12% H: 4.93% C: 2.34%
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| -4.51% | O: -0.3% H: 0.0% C: 0.0%

Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 | DelveInsight
Published: 2024-04-08 (Crawled : 22:00) - prnewswire.com
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| -4.51% | O: -0.3% H: 0.0% C: 0.0%
LLY | $745.04 -0.12% 410K

|

Health Technology

| -3.41% | O: 0.05% H: 0.02% C: -2.62%
MOR | $18.01 -0.22% 13K

|

Health Technology

| -0.55% | O: 0.06% H: 0.22% C: 0.0%
KNSA | $16.86 -0.12% 44K

|

Health Technology

| -4.52% | O: 0.23% H: 1.58% C: 0.06%
IMAB | $1.795 -0.28% 52K

|

Health Technology

| -0.55% | O: -0.55% H: 1.39% C: 0.0%
GLPG | $28.95 0.14% 13K

|

Health Technology

| -8.29% | O: 0.0% H: 0.39% C: -0.66%
positive growth market

CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy
Published: 2024-04-06 (Crawled : 04:20) - prnewswire.com
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| Email alert Add to watchlist
carvykti fda first approved one treatment for therapy

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Shockwave Medical, Inc.
Published: 2024-04-05 (Crawled : 19:00) - prnewswire.com
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| Email alert Add to watchlist
ETRN | $12.355 0.86% 1.1M

|

Industrial Services

| Email alert Add to watchlist
SWAV | $327.81 0.09% 270K

|

Health Technology

| Email alert Add to watchlist
ADTH | $3.195 0.16% 170K

|

| Email alert Add to watchlist
acquisition

Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm
Published: 2024-04-05 (Crawled : 18:00) - prnewswire.com
SUN | $54.93 1.03% 10K

|

Distribution Services

| -8.46% | O: 0.0% H: 0.14% C: -1.49%
NS | $22.03 1.76% 28K

|

Distribution Services

| -6.45% | O: -0.44% H: 0.96% C: -0.09%
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| -6.72% | O: -1.84% H: 0.0% C: 0.0%
SWAV | $327.81 0.09% 270K

|

Health Technology

| 1.83% | O: 1.21% H: 0.65% C: 0.25%
KTRA | $0.1181 10.79% 3.3M

|

Distribution Services

| -30.41% | O: -13.08% H: 8.09% C: 4.16%
ABIO | $3.21 -1.23% 7.4K

|

Health Technology

| 4.22% | O: -3.9% H: 7.09% C: 4.39%

Gene Therapies in Ophthalmology Market to Register Immense Growth at a CAGR of 57.8% by 2034 | DelveInsight
Published: 2024-04-04 (Crawled : 22:00) - prnewswire.com
ALPMY | $9.47 520K

|

| -11.72% | O: -0.52% H: 0.71% C: 0.71%
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| -6.72% | O: -1.84% H: 0.0% C: 0.0%
SLDB | $9.18 -0.86% 20K

|

Health Technology

| -19.31% | O: -0.73% H: 1.3% C: -1.06%
growth market

Retinitis Pigmentosa Market to Grow Rapidly at a CAGR of 16.8% by 2034 | DelveInsight
Published: 2024-04-02 (Crawled : 22:00) - prnewswire.com
ALPMY | $9.47 520K

|

| -13.44% | O: -0.65% H: 2.43% C: -0.28%
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| -8.1% | O: 0.02% H: 0.0% C: 0.0%
market

Diabetic Kidney Disease Market to Witness Upsurge in Growth at a CAGR of ~6.5% by 2034 | DelveInsight
Published: 2024-04-01 (Crawled : 22:00) - prnewswire.com
PKX | News | $70.68 0.83% 9.6K

|

Non-Energy Minerals

| -8.41% | O: -0.77% H: 0.0% C: -0.85%
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| -8.13% | O: -0.77% H: 0.8% C: 0.74%
disease kidney growth market diabetic

Don Casey Joins Avista Capital Partners as a Strategic Executive
Published: 2024-04-01 (Crawled : 16:00) - prnewswire.com
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| -8.35% | O: -0.28% H: 0.27% C: 0.04%

Turbine and Harmonic Discovery Pair Simulation-Guided Biology and Multi-Target Kinase Inhibition Chemistry Expertise to Develop a Novel Cancer Therapy
Published: 2024-04-01 (Crawled : 11:00) - prnewswire.com
JNJ | News | $146.315 0.4% 1.3M

|

Health Technology

| -8.35% | O: -0.28% H: 0.27% C: 0.04%
cancer therapy

Gainers vs Losers

83%

17%

Top 10 Gainers

AGBA | News | $1.37 242.5% 76M

|

EGOX | $0.0835 131.94% 160M

|

ZCMD | $2.18 50.35% 24M

|

Commercial Services

CHRO | $1.73 41.22% 46K

|

RWOD | $10.61 32.68% 5.1M

|

NVFY | $2.77 31.28% 2.2M

|

Consumer Durables

AULT | $0.3174 31.1% 28M

|

WISA 4 | $7.11 20.71% 4.7M

|

Electronic Technology

LIFW | News | $0.99 19.26% 800K

|

Administrative and Support and ...

PRTG | $0.285 18.75% 140K

|

Mining, Quarrying, and Oil and ...

Your saved searches

Save your searches and get alerts when important news are released.